# October 2026 implementation and verification

Integration owner: the main Codex agent. Independent academic, clinical and peer reviewers review the proposal and final implementation; they do not edit shared files.

## Execution plan

1. Inspect clean baseline, render representative routes, read latest source. Complete.
2. Reconcile one content model; implement portrait-led editorial system and six bilingual essential pages. Complete.
3. Inspect browser renders, fix findings, run production checks and regression tests. Complete.
4. Hand off preview, maintenance commands and bounded external follow-ups. Complete. The subsequent user request authorizes a GitHub review branch and pull request; merge, production deployment, DNS and account changes remain outside scope.

## Source and decisions

- Actual `FelipeCVLatest.docx`, supplied in this chat, core modified 2026-10-21 21:27:51 UTC; read all paragraphs, hyperlinks and structure (no tables/images). Source copied byte-for-byte to stable DOCX download. PDF exported from that copy.
- October CV establishes five under-review manuscripts and seven SCCM 2027 abstracts accepted for presentation. Propofol abstract has no byline; left absent. Exact UGIB title and journal updated. Exact AHA title omits “Blood”; retained as printed, linked to HTK study by matching PROSPERO registration.
- September source supports ongoing opioid and TBI studies and general review/computational experience. Absence from October selective CV is not cancellation. Per-study responsibilities beyond listed authorship remain unverified. General review experience is not assigned to individual cases.
- Prior cerebral-autoregulation submission retained as a research project without a current conference-decision claim; UGIB study remains. Old pending list replaced, no rejection inferred.
- Clinia adoption figure omitted from web copy because neither activity definition nor measurement date is established. Source DOCX/PDF preserves the actual CV wording. No personal audience attributed from Afya platform figures.
- Existing portrait is displayed through a head-and-shoulders CSS crop excluding lower-chest credential embroidery. No image alteration.
- Route groups provide static English and Portuguese HTML documents and a localized shell, while preserving all public paths. Scientific citations remain in their original language.
- Preferred production host is `www.felipef.com`. Redirect is configured in Next, with production edge behavior to verify at deployment.

## External resources

- Clinia README and package.json read through GitHub connector. README still advertises patient management, validated calculators, encryption/HIPAA-ready claims, placeholder `seu-usuario` clone/issues/wiki paths. LICENSE lookup returns 404. No security assessment performed and no external repo modified. Portfolio says “View source”, not a verified license claim.

## Three-perspective reviews and fixes

All three independent agents reviewed the proposal and the implementation. The main agent integrated every change.

- Academic: verified exact SCCM and manuscript records, distinct remimazolam questions, AHA citation, source DOCX and all PDF pages. Removed an unsupported UGIB eligibility assertion; changed the CV section to “Additional research” because cerebral-autoregulation stage is unresolved. A dev-HMR issue was reported; production search/hydration tests passed, and local dev origin configuration was corrected.
- Clinical: verified training stage and portrait crop, bounded study questions, UGIB journal, and honest Clinia scope. Fixed a 320px name/portrait overlap, corrected the web-only “alamandine” spelling, and clarified Portuguese contact wording. The original CV bytes and faithful PDF retain source wording.
- Peer: verified mobile composition, contact, search, language switching and history. Fixed singular record counts and stopped unrelated query strings carrying into About.
- Integration inspection: replaced unsupported arrow glyphs with SVG, restored a branded 404 through route-group fallbacks, moved legacy redirects into Next configuration, and served the social image through an explicit static route to remove localhost metadata from redirect fallbacks. No production host behavior was claimed from these local changes.

## Executed verification

- Production build and TypeScript check pass. Existing package manager/lockfile and dependencies retained. No lint command is defined.
- Full Playwright regression suite: **17 passed** (46.9 seconds on the final visual/routing implementation). After the final visibility-filter adjustment, all **7 targeted research, CV, localization, redirect and metadata tests passed** (10.5 seconds). A later accessible-name cleanup was checked with Lighthouse and a final browser smoke pass.
- Chromium screenshots: **51 route/theme/viewport states**. All 16 content routes loaded successfully. Representative templates were checked at 320, 390, 768 and 1440 CSS px; all captured states had no page-level horizontal overflow. All changed routes were viewed; deeper mobile/dark inspection covered home, research, software, contact and long-form writing.
- Axe checks across all 16 content routes at 390/1440px in light/dark themes: no violations. Keyboard checks covered skip link, menu focus boundary, Escape, focus restoration, route changes and desktop resize. Theme persistence, storage denial, reduced motion, clipboard success/failure, English/Portuguese navigation, URL query/filter state, browser Back, reset, empty results, internal links and 404 status pass.
- Text enlargement: every element's computed font size doubled at 1280px for representative routes; no page overflow. Reflow checked at 320 CSS px, equivalent to 400% reflow from 1280px. This is not a claim of testing every browser's native zoom UI or assistive technology.
- Calculated normal-text contrast on paper/raised/surface roles: minimum **5.21:1 light**, **7.34:1 dark**. Focus contrast minimum **4.94:1 light**, **7.36:1 dark**. Essential input/filter control borders exceed 3:1 on their actual backgrounds. Divider lines are decorative. Primary controls target at least 44px; inline text-link exceptions are not described as universal 44px targets.
- DOCX byte-for-byte parity with supplied attachment: pass. PDF text parity after whitespace/footer normalization: pass. All three PDF pages visually inspected; no clipped entries. Stable PDF/DOCX download URLs and file signatures pass; PDF is typeset, not tagged for full PDF accessibility.
- Canonicals, language alternates, sitemap, social-image URL, legacy article redirects and host-based 308 behavior tested locally. Only live deployment can establish behavior of pre-existing hosting rules.
- Final production smoke: Home at 1440/390px, Writing, Portuguese CV and custom 404 render without page overflow or unexpected console/network/runtime errors. The 404 returns 404; social image returns a PNG with status 200. Header home link exposes its visible name. Final viewport screenshots were inspected after the accessible-name change.

## Performance measurements

Lighthouse 12.8.2 against the local production build in Chromium, simulated mobile (412 × 823, 4× CPU slowdown, 150ms RTT / approximately 1.6Mbps). One isolated measurement per route is reported; these are lab measurements, not field Core Web Vitals or a guarantee on other hardware/networks.

| Route | Performance | Accessibility | Best practices | SEO | FCP | LCP | TBT | CLS |
|---|---:|---:|---:|---:|---:|---:|---:|---:|
| Home | 99 | 100 | 100 | 100 | 0.8s | 2.1s | 30ms | 0 |
| Research | 99 | 100 | 100 | 100 | 0.8s | 2.0s | 30ms | 0 |

The Home measurement was repeated after correcting the header link's accessible name; the warning is resolved. Reports: `/workspace/felipe-preview/lighthouse-home-final.json` and `lighthouse-research-final.json`. No Safari, Firefox, screen-reader or field-performance validation was available in this run. Automated accessibility results are not full conformance certification.

## External checks and remaining follow-ups

- GitHub Clinia repository, README and package.json were readable. README clone path still uses `seu-usuario`; linked `LICENSE` returned 404. The README's license statement was not removed or replaced. Product claims about calculators, patient management, encryption and HIPAA readiness remain an external documentation reconciliation task, not an established security finding.
- GitHub's actual advertised homepage is `https://clinia-smoky.vercel.app`. The current attempt to fetch it was blocked by this environment's HTTP destination policy (proxy CONNECT 403). The earlier brief reported `DEPLOYMENT_NOT_FOUND`; this run cannot establish whether that remains true. The website exposes source and a labeled synthetic walkthrough, with no unverified live-demo button.
- PROSPERO and DOI/OSF fetches were likewise blocked by destination policy. Identifiers are verified against the supplied CV/September record, but destination resolution is unverified in this run. Live LinkedIn and the new primary-reference destinations were not independently browser-verified here.
- Factual follow-ups: supply the missing propofol-abstract byline if available; document specific study responsibilities beyond authorship; establish relationships among the remimazolam outputs before linking them; resolve the older cerebral-autoregulation conference submission separately. A defined Clinia user metric is needed only if a count is to be restored.
- Deployment remains a separate final decision. Following local verification, the user requested a GitHub pull request, authorizing commit and push of the website changes for review. No merge, production deployment, DNS, permission or separate Clinia repository write is included. Recheck the preferred-host redirect at the owning hosting edge and external evidence/demo links before production publication.

## Maintenance and handoff

Use `README.md` for exact run commands, content locations, bilingual maintenance and the CV export workflow. The production preview runs on port 3001 in this execution workspace. Screenshots and machine-readable inspection/performance results are in `/workspace/felipe-preview`; they are review artifacts outside the repository. The local URL is not a public deployment or a guaranteed forwarded endpoint on another computer.
